Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC) - Join Clinical Trial NCTNCT06904235
How to Join This Clinical Trial - NCTNCT06904235
Learn how to participate in this PHASE2 trial studying an investigational therapy for Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06904235 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 18 locations. Find a study site near you:
Clinical Research Site
Athens, - Greece
Status: NOT_YET_RECRUITING
Clinical Research Site
Thessaloniki, - Greece
Status: NOT_YET_RECRUITING
Clinical Research Site
Bialystok, - Poland
Status: RECRUITING
Clinical Research Site
Olsztyn, - Poland
Status: NOT_YET_RECRUITING
Clinical Research Site
Poznan, - Poland
Status: RECRUITING
Clinical Research Site
Szczecin, - Poland
Status: NOT_YET_RECRUITING
Clinical Research Site
Szczecin, - Poland
Status: RECRUITING
Clinical Research Site
Warsaw, - Poland
Status: RECRUITING
Clinical Research Site
Warsaw, - Poland
Status: RECRUITING
Clinical Research Site
Łodz, - Poland
Status: NOT_YET_RECRUITING
And 8 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships